Immune selective pressure and HLA class I antigen defects in malignant lesions

By Chang Chien-Chung   Ferrone Soldano  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite

HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors – Considerations for Successful Immunotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1094-1100

Bentham Science Publishers

Access to resources Recommend Favorite

HLA Class I Expression, Tumor Escape and Cancer Progression

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 105-110

Bentham Science Publishers

Access to resources Recommend Favorite

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

By Algarra Ignacio   García-Lora Angel   Cabrera Teresa   Ruiz-Cabello Francisco   Garrido Federico  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 904-910

Springer Publishing Company

Access to resources Recommend Favorite

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

By Aptsiauri Natalia   Carretero Rafael   Garcia-Lora Angel   Real Luis   Cabrera Teresa   Garrido Federico  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1727-1733

Springer Publishing Company

Access to resources Recommend Favorite